220
Participants
Start Date
July 5, 2007
Primary Completion Date
September 2, 2008
Study Completion Date
September 2, 2008
Naproxen
Oral naproxen 500 mg twice daily for Weeks 1-12.
Placebo
Single IV infusion of placebo on Day 1 and placebo for naproxen twice daily for Weeks 1-12.
PF-04383119 (RN624)
Single IV infusion of 200 micrograms/kg RN624 on Day 1
The Medical Research Network, LLC, New York
Allegheny Pain Management, Altoona
Independence Family Medicine, Virginia Beach
Wake Internal Medicine Consultants, Inc., Raleigh
Wake Research Associates, Raleigh
North State Clinical Research, PLLC, Lenoir
Radiant Research, Greer
Doctors Medical Center of Walton County, DeFuniak Springs
SJS Clinical Research, Inc., Destin
Adult Medicine Specialists, Longwood
Genesis Research International, Longwood
Collier Neurologic Specialists, Naples
Radiant Research, Birmingham
Pinnacle Research Group LLC, Anniston
Advanced Therapeutics, Inc., Johnson City
Johnson City Internal Medicine, Johnson City
Spence Medical Research, Picayune
Radiant Research, Inc., St Louis
Cotton-O'Neil Clinical Research, Topeka
Cotton-O'Neil Clinic, Topeka
Heartland Research Associates, Wichita
Quality Clinical Research, Inc., Omaha
Advances In Health, Inc., Houston
Centex Research, Nassau Bay
Immediate Medical Care, Nassau Bay
DiscoveResearch, Incorporated, Bryan
Radiant Research San Antonio, San Antonio
Radiant Research - Phoenix Southeast, Chandler
Radiant Research, Scottsdale
University of California San Diego, San Diego
Advanced Clinical Research Institute, Anaheim
Summit Research Network (Oregon), Inc., Portland
Summit Research Network (Seattle) LLC, Seattle
Northeast Medical Research Associates, Inc, North Dartmouth
Clinical Pharmacology Study Group, Worcester
New England Center for Clinical Research, Cranston
Partners in Clinical Research, Cumberland
Omega Medical Research, Warwick
Lead Sponsor
Pfizer
INDUSTRY